Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

Cancer isn't just about broken genes—it's about broken architecture. Imagine a city where roads suddenly vanish, cutting off ...

The mammalian elongation complex has remained a mystery – until researchers discovered how it controls its speed.

North America currently leads the DNA Synthesis Market due to its mature biotech ecosystem, heavy investment in genomics, and ...

A new portable DNA test can identify dozens of shark and ray species in only two hours, giving frontline officers a powerful ...

A team from the Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER) has developed an innovative ...

Industrialized, small batch, and individual RNA therapeutics become practical with “in-a-box” manufacturing technology.

Experts shared their insights with Technology Networks, offering a glimpse into a future where automation and intelligence work hand in hand.

Tech-savvy parents to be are using IVF and screening embryos to build families in ways that were unimaginable a few short years ago.

EMBL researchers have created a new AI tool that uses a “molecular laser tag” approach to identify cells capable of revealing the earliest origins of cancer. The human body depends on accurate genetic ...

Humanity is generating data faster than it can be stored, and the hard drives and tape libraries that quietly underpin the cloud are already straining to keep up. As the gap widens between what we ...

TEL AVIV, Israel & LEHI, Utah & HOUSTON & FREMONT, Calif.--(BUSINESS WIRE)--MyHeritage, the leading global platform for family history and DNA testing, announced today a landmark move to Whole Genome ...